ANCA glomerulonephritis after the Moderna COVID-19 vaccination

Kidney Int. 2021 Aug;100(2):473-474. doi: 10.1016/j.kint.2021.05.017. Epub 2021 May 31.

Authors

Arjun Sekar¹, Ruth Campbell², Jad Tabbara³, Prerna Rastogi⁴

Affiliations

¹ Associates in Kidney Care, Des Moines, Iowa, USA. Electronic address: arjun_sekar@hotmail.com.
² University of Colorado, Aurora, Colorado, USA.
³ Cleveland Clinic, Cleveland, Ohio, USA.
⁴ University of Iowa Hospitals, Iowa, USA.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

2019-nCoV Vaccine mRNA-1273
Antibodies, Antineutrophil Cytoplasmic
COVID-19 Vaccines / adverse effects*
COVID-19* / prevention & control
Glomerulonephritis* / chemically induced
Humans
Male
Middle Aged
Vaccination / adverse effects

Substances

Antibodies, Antineutrophil Cytoplasmic
COVID-19 Vaccines
2019-nCoV Vaccine mRNA-1273